Re-Engaging Cross-Reactive Memory B Cells: The Influenza Puzzle
Authors:
Open Access
- 1 January 2012
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 3, 22062
Abstract
The emergence of a novel influenza A virus strain into humans poses a continuous public health threat. Vaccination is the most effective means of protection against influenza. The generation of memory B cells and long-lived plasma cells that can maintain protective levels of influenza-specific antibodies for protracted periods of time is the foundation for the success of such vaccines. Influenza vaccines elicit an antibody response that is primarily targeting viral surface glycoproteins. However, frequent amino acid mutations within the immunodominant epitopes allow the virus to efficiently escape neutralization by pre-existing antibodies and consequently cause annual epidemics and occasional pandemics. Recently, monoclonal antibodies (mAbs) that target subdominant influenza epitopes have been extensively characterized. These epitopes are immunogenic, can mediate virus neutralization, and most importantly are conserved among different influenza strains. It remains puzzling, however, that despite being repeatedly exposed to such conserved domains of influenza hemagglutinin (HA) either in the form of vaccination or natural infection, most humans do not develop immunological memory that can provide broad protection against emerging virus strains. Here we will discuss the conditions that may be required for engaging such cross-reactive memory B cells in the immune response to influenza infection and vaccination in humans.Keywords
This publication has 43 references indexed in Scilit:
- A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus HemagglutininJournal of Virology, 2011
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A HemagglutininsScience, 2011
- Memory B and memory plasma cellsImmunological Reviews, 2010
- Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccineJournal of Clinical Investigation, 2010
- Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009New England Journal of Medicine, 2009
- Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B CellsPLOS ONE, 2008
- Humoral immunity and long-lived plasma cellsCurrent Opinion in Immunology, 2002
- Immunological Memory and Protective Immunity: Understanding Their RelationScience, 1996
- Structural Basis of Immune Recognition of Influenza Virus HemagglutininAnnual Review of Immunology, 1990
- The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)Cell, 1982